AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8458531
Drug: gemfibrozil 1200
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gemfibrozil 1200 mg daily for 12 weeks
Trial: 3426682
Drug: Calcium carbimide
RxNorm normalized name: calcium carbimide
DrugBank: Calcium carbimide (DB09116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium carbimide (50 mg)
Trial: 22339708
Drug: Tremella mesenterica
RxNorm normalized name: Tremella fuciformis whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tremella mesenterica (Tm) 2 g
Trial: 22339708
Drug: Tremella mesenterica
RxNorm normalized name: Tremella fuciformis whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tremella mesenterica (Tm) with omeprazole 20 mg
Trial: 22339708
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1000 mg (standard triple therapy)
Trial: 20556775
Drug: Inhaled oxygen
RxNorm normalized name: oxygen Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled oxygen (at normal pressure)
Trial: 16044078
Drug: Nicorandil (4‐6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (4‐6 mg/h)
Trial: 12182991
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg q.i.d. for 7 days
Trial: 8582435
Drug: etofibrate 500
RxNorm normalized name: etofibrate 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etofibrate 500 mg/day for 5 days
Trial: 8582435
Drug: bezafibrate 400
RxNorm normalized name: bezafibrate 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bezafibrate 400 mg/day for 5 days
Trial: 2153424
Drug: R68070 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R68070 (400 mg)
Trial: 2153424
Drug: Aspirin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (400 mg)
Trial: 7029741
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amoxycillin and flucloxacillin (Suprapen; Bencard)
Trial: 7029741
Drug: Antibiotics only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics only if postoperative sepsis developed (Control)
Trial: 28698331
Drug: Atraumatic restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic restorative treatment (ART) using high-viscosity glass ionomer cement
Trial: 18422764
Drug: Duloxetine 40
RxNorm normalized name: duloxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 40 mg twice daily
Trial: 17498126
Drug: Benazepril (2.5-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril (2.5-5 mg)
Trial: 16177001
Drug: Pilocarpine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine (5 mg oral solution)
Trial: 7608283
Drug: Beta-blocker bisoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker bisoprolol (4.25 +/- 1.2 mg/day) for 4 months
Trial: 7608283
Drug: Levothyroxine (L-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (L-T4) therapy
Trial: 2172309
Drug: Diet-laxative (DL)
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet-laxative (DL) group
Trial: 6820492
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of 1500 mg sodium valproate
Trial: 6820492
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of 1500 mg sodium valproate
Trial: 26721141
Drug: Relaxing needling
RxNorm normalized name: Relax-DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxing needling manipulation combined with exercise therapy (Group A)
Trial: 26721141
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (Group B)
Trial: 23795874
Drug: Buprenorphine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine treatment (cocaine users)
Trial: 19124099
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg iodine/ml (Iopromide 300)
Trial: 19124099
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg iodine/ml (Iomeprol 400)
Trial: 15804728
Drug: Low-dose hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose hormone therapy (HT)
Trial: 12470755
Drug: latanoprost 0.005%
RxNorm normalized name: LATANOPROST 0.005% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: latanoprost 0.005% once daily
Trial: 12470755
Drug: unoprostone 0.15%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: unoprostone 0.15% twice daily
Trial: 2889957
Drug: APD (aminohydroxy-propylidene-bisphosphonate),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APD (aminohydroxy-propylidene-bisphosphonate), 300 mg daily (n = 70)
Trial: 12207762
Drug: Dead Sea
RxNorm normalized name: Cleanser Topical application Soap [MG217 DEAD SEA SOAP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dead Sea climatotherapy/pseudocatalase cream (PC-KUS)
Trial: 12207762
Drug: Dead Sea
RxNorm normalized name: Cleanser Topical application Soap [MG217 DEAD SEA SOAP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dead Sea climatotherapy/placebo cream
Trial: 12207762
Drug: Conventional pseudocatalase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional pseudocatalase monotherapy
Trial: 12207762
Drug: Narrowband UVB
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Narrowband UVB activated pseudocatalase cream (PC-KUS)
Trial: 27281373
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy for SAD (CBT-SAD)
Trial: 27033936
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide releasing solution (NORS)
Trial: 27033936
Drug: Tilmicosin (macrolide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilmicosin (macrolide antibiotic)
Trial: 20300753
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy (methylprednisolone)
Trial: 16006882
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository (DS)
Trial: 16006882
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of lidocaine PPNB and DS
Trial: 12479658
Drug: Adjunctive antidepressant
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive antidepressant
Trial: 10342350
Drug: Active ultrasound
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active ultrasound treatment (20 minutes daily for 75 days)
Trial: 10342350
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (20 minutes daily for 75 days)
Trial: 10342350
Drug: Active ultrasound
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active ultrasound treatment
Trial: 7718317
Drug: Weekly 20
RxNorm normalized name: buprenorphine
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly 20 mg mitoxantrone intravesically for 6 weeks after TUR
Trial: 7185773
Drug: Prazepam (tranquillizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazepam (tranquillizing agent)
Trial: 31039579
Drug: Prefrontal tDCS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prefrontal tDCS (transcranial direct current stimulation) administered to the left prefrontal cortex prior to CBT for eight weekly sessions
Trial: 28427826
Drug: Suvorexant 15
RxNorm normalized name: suvorexant 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suvorexant 15 mg
Trial: 28427826
Drug: Suvorexant 30
RxNorm normalized name: Suvorexant
DrugBank: Suvorexant (DB09034)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suvorexant 30 mg
Trial: 23829494
Drug: Racemic salbutamol
RxNorm normalized name: EPINEPHRINE,RACEMIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic salbutamol (200 μg q.i.d.)
Trial: 23829494
Drug: Levosalbutamol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosalbutamol (100 μg q.i.d.)
Trial: 19003983
Drug: Etoposide (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide (single agent)
Trial: 15893351
Drug: Killed whole‐cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Killed whole‐cell Leishmania amazonensis vaccine (3 doses at 20-day intervals)
Trial: 15893351
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 doses at 20-day intervals)
Trial: 7511324
Drug: Dextran-coated superparamagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran-coated superparamagnetic iron oxide particles (BMS 180549) at a dose of 1.7 mg Fe/kg
Trial: 7511324
Drug: Dextran-coated superparamagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran-coated superparamagnetic iron oxide particles (BMS 180549) at doses ranging from 0.3 to 1.7 mg Fe/kg
Trial: 28158524
Drug: Participatory trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participatory trial intervention (details on dosage and duration not available)
Trial: 25582785
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of lidocaine and bupivacaine
Trial: 20183690
Drug: Guided Internet-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided Internet-delivered self-help treatment (5 weekly text modules, video exposure, Internet support)
Trial: 20183690
Drug: Live-exposure treatment
RxNorm normalized name: Typhoid Vaccine Live
DrugBank: Typhoid Vaccine Live (DB11050)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live-exposure treatment (1 session of 3 hours following a brief orientation)
Trial: 16929589
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of interferon alfa-2b plus ribavirin for 48 weeks
Trial: 16929589
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of interferon alfa-2b plus ribavirin
Trial: 11087644
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (pre-operative and intraoperative radiotherapy)
Trial: 8967308
Drug: Non-fractioned heparin
RxNorm normalized name: OMIDUBICEL NON-CULTURED FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fractioned heparin (Liquemine)
Trial: 8967308
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Fraxiparine)
Trial: 4083303
Drug: Evening dosing
RxNorm normalized name: Evening Dosing 24 HR Jornay 60 MG Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dosing with Uniphyl (10 P.M.)
Trial: 4083303
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing with Uniphyl (8 A.M.)
Trial: 23534865
Drug: Folate-fortified oral
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate-fortified oral contraceptive (OC)
Trial: 23534865
Drug: Marketed oral
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketed oral contraceptive (OC)
Trial: 22640829
Drug: Bevacizumab 10
RxNorm normalized name: bevacizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 10 mg/kg days 1 and 15; paclitaxel 90 mg/m(2) days 1, 8, and 15, every 4 weeks (Arm A)
Trial: 22640829
Drug: Bevacizumab 15
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab 15 mg/kg day 1; capecitabine 1000 mg/m(2) b.i.d., days 1‐14, every 3 weeks (Arm B)
Trial: 15246599
Drug: 23-valent polysaccharide
RxNorm normalized name: pneumococcal 23-valent polysaccharide vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent polysaccharide vaccine
Trial: 1661490
Drug: Transcranial electric
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transcranial electric stimulation (TES) combined with pharmacotherapy (group I)
Trial: 6762889
Drug: Pirenzepine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (50 mg three times a day for 4 weeks)
Trial: 25192282
Drug: Low-dose helical
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose helical CT scan for lung cancer screening (NLST)
Trial: 22958426
Drug: Taspoglutide 10
RxNorm normalized name: Taspoglutide
DrugBank: Taspoglutide (DB14027)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taspoglutide 10 mg
Trial: 22958426
Drug: Taspoglutide 20
RxNorm normalized name: Taspoglutide
DrugBank: Taspoglutide (DB14027)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taspoglutide 20 mg
Trial: 16733277
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for giardiasis
Trial: 11020032
Drug: Knowledge of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge of drugs taken prior to admission
Trial: 11020032
Drug: Knowledge of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge of drugs received during hospitalization
Trial: 11020032
Drug: Importance rating
RxNorm normalized name: Aratinga erythrogenys feather extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Importance rating of drug characteristics
Trial: 11020032
Drug: Sources of
RxNorm normalized name: Dental Resources brand of Stannous Fluoride Dental Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sources of drug information
Trial: 9032890
Drug: Lipoprotein OspA
RxNorm normalized name: Lipoprotein OspA antigen recombinant
DrugBank: Lyme disease vaccine (recombinant OspA) (DB00045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipoprotein OspA vaccine
Trial: 9032890
Drug: Unlipidated OspA
RxNorm normalized name: OspA protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unlipidated OspA vaccine
Trial: 9032890
Drug: Lipidated OspA
RxNorm normalized name: OspA protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipidated OspA vaccine
Trial: 1891755
Drug: TXA2 synthetase
RxNorm normalized name: nitric oxide synthase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA2 synthetase inhibitor (Cataclot) administered to 13 patients by continuous drip infusion at a dose of 1 microgram/kg/min for 8 to 14 days (group A)
Trial: 19257800
Drug: Aliskiren/amlodipine 300/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren/amlodipine 300/10 mg
Trial: 22303911
Drug: Aliskiren/amlodipine 150/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren/amlodipine 150/10 mg
Trial: 19914303
Drug: Cefaclor (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (1000 mg)
Trial: 17516958
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate tablet (150 g tablet, containing 50 mg of elemental iron) daily throughout pregnancy
Trial: 16271570
Drug: Forced-use therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forced-use therapy (FUT) combined with conventional rehabilitation program
Trial: 9659093
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml 75% sucrose solution
Trial: 2556172
Drug: Lisinopril 80
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril 80 mg once daily
Trial: 2556172
Drug: Lisinopril 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 1.25 mg once daily
Trial: 2556172
Drug: Lisinopril 5
RxNorm normalized name: lisinopril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 5 mg once daily
Trial: 31423822
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care and electrical stimulation to wrist flexors and extensors for 30 minutes, twice a day, five days a week for three months
Trial: 19843803
Drug: Gabapentin 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 1.2 g and bolus plus infusion of saline
Trial: 19843803
Drug: Ketamine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.3 mg/kg IV bolus and 0.05 mg/kg/h infusion until the end of surgery
Trial: 19843803
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received oral placebo capsules and bolus plus infusion of saline
Trial: 18269691
Drug: Drotrecogin alfa
RxNorm normalized name: Drotrecogin Alfa
DrugBank: Drotrecogin alfa (DB00055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drotrecogin alfa (activated; DrotAA) at standard therapy (24 mug/kg per hour for 96 hours)
Trial: 18269691
Drug: Drotrecogin alfa
RxNorm normalized name: Drotrecogin Alfa
DrugBank: Drotrecogin alfa (DB00055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drotrecogin alfa (activated; DrotAA) at alternative therapy (higher dose with variable infusion duration or variable infusion duration only)
Trial: 18269691
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (DrotAA)
Trial: 18269691
Drug: Alternative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative therapy (DrotAA)
Trial: 18269691
Drug: DrotAA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DrotAA therapy
Trial: 11679387
Drug: Metformin usage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin usage in intervention group
Trial: 27517958
Drug: Protein breakfast
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein breakfast (PRO; 350 kcal; 39 g CHO, 30 g PRO, 8 g fat)
Trial: 27517958
Drug: Carbohydrate breakfast
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate breakfast (CHO; 351 kcal; 59 g CHO, 10 g PRO, 8 g fat)
Trial: 21927920
Drug: Denosumab 14
RxNorm normalized name: Denosumab
DrugBank: Denosumab (DB06643)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Denosumab 14 mg
Trial: 21927920
Drug: Denosumab 100
RxNorm normalized name: Denosumab
DrugBank: Denosumab (DB06643)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Denosumab 100 mg
Trial: 21927920
Drug: Denosumab (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (all doses)
Trial: 19098692
Drug: Intramuscular acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular acupuncture
Trial: 12534029
Drug: 24 mg
RxNorm normalized name: uracil 224 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 mg of betamethasone (12 mg every 24 hours)
Trial: 3480840
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of oxytocin
Trial: 28836381
Drug: Tongue cleaning
RxNorm normalized name: beef tongue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongue cleaning with mouth moisturising gel
Trial: 24898233
Drug: Daily breakfast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily breakfast (≥700 kcal before 1100)
Trial: 21765272
Drug: Multimodal physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal physical therapy program plus deep-water running
Trial: 21765272
Drug: Multimodal physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal physical therapy program alone
Trial: 11742706
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus vinorelbine (G+V) 1200 mg/m(2) plus 30 mg/m(2) on days 1 and 8 every 3 weeks
Trial: 11742706
Drug: Vinorelbine (V)
DrugBank: Vinorelbine (DB00361)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vinorelbine (V) 30 mg/m(2) on days 1 and 8 every 3 weeks
Trial: 11742706
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus vinorelbine (G+V)
Trial: 29677302
Drug: Perioperative behavioral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative behavioral therapy and pelvic floor muscle training (BPMT)
Trial: 10647316
Drug: Spinal manipulation
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulation plus soft tissue therapy